The American Society of Clinical Oncology and the National Comprehensive Cancer Network collaborated to jointly develop a new guideline to help clinicians recognize and manage the range of side effects from immune checkpoint inhibitors.
August 2026 | Volume 19 | No 3
To sign up for our newsletter or print publications, please enter your contact information below.